Case Report
Accepted on 19 Nov 2025
Pitfalls in CF screening – targeted variant analysis can cause misleading results and therapy recommendations
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
Type at least 3 characters
184 articles
Original Research
Published on 23 Oct 2025
aiGeneR 3.0: an enhanced deep network model for resistant strain identification and multi-drug resistance prediction in Escherichia coli causing urinary tract infection using next-generation sequencing data
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2025.1651917
- 1,342 views
Original Research
Published on 25 Sep 2025
Concordance of an in-house 2-steps PCR-SSP and nanopore sequencing for HLA-B*57:01 and HLA-B*58:01 typing: a comparative study
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2025.1649990
- 4,030 views
Correction
Published on 08 Jul 2025
Correction: Clinical impact of pharmacogenomics in pediatric care: insights extracted from clinical exome sequencing
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2025.1639666
- 2,031 views
Review
Published on 24 Jun 2025
Gene polymorphisms associated with immunosuppressant adverse effects in systemic lupus erythematosus: a narrative review
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2025.1594648
- 3,929 views
Case Report
Published on 17 Jun 2025
Case Report: Successful late-line pralsetinib treatment in an ALK-rearranged lung adenocarcinoma patient with KIF5B-RET fusion resistant to alectinib
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2025.1569912
- 3,009 views
Original Research
Published on 04 Jun 2025
NOS3 rs3918188C>A is associated with susceptibility to resistant hypertension while CES1 genetic variation was not associated with resistant hypertension among South Africans
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2025.1608423
- 2,962 views
Original Research
Published on 29 May 2025
Clinical impact of pharmacogenomics in pediatric care: insights extracted from clinical exome sequencing
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2025.1574325
- 3,078 views
Original Research
Published on 20 May 2025
Lack of association between genetic variations in CYP3A5 and blood pressure or hypertension risk in the UK biobank
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2025.1490863
- 1,754 views
Review
Published on 30 Apr 2025
Leveraging long-read sequencing technologies for pharmacogenomic testing: applications, analytical strategies, challenges, and future perspectives
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2025.1435416
- 3,941 views
- 5 citations
Original Research
Published on 17 Apr 2025
Correlation between gene polymorphisms and perioperative analgesia in patients undergoing gynecological surgery
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2025.1509042
- 1,505 views
Systematic Review
Published on 20 Feb 2025
Correlation and clinical significance of GSTP1 hypermethylation in hepatocellular carcinoma: a systematic review and meta-analysis
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2025.1543261
- 2,495 views
Original Research
Published on 23 Oct 2024
Roles of NR1I3 and NR1H4 polymorphisms in the susceptibility to antituberculosis drug-induced liver injury in China: a case‒control study
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2024.1428319
- 1,876 views
Original Research
Published on 11 Sep 2024
Ninein, a candidate gene for ethanol anxiolysis, shows complex exon-specific expression and alternative splicing differences between C57BL/6J and DBA/2J mice
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2024.1455616
- 1,800 views
- 2 citations
Mini Review
Published on 30 Aug 2024
Human sulfotransferase SULT2B1 physiological role and the impact of genetic polymorphism on enzyme activity and pathological conditions
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2024.1464243
- 3,227 views
- 7 citations
Editorial
Published on 20 Aug 2024
Editorial: Utilization of pharmacogenomics in clinical practice
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2024.1470698
- 1,776 views